News Posts List
Could Aspirin be a Viable Adjuvant Treatment for Cancer?
10/21/2011
Dr. Ruth E Langley and colleagues provide an overview of the evidence in favor of aspirin in cancer despite aspirin being neither new nor expensive, in a recent review in the British Journal of Cancer (British Journal of Cancer...
Don't Let Congress Hurt America's Charities
10/21/2011
A powerful group of Senators is proposing to significantly reduce key tax benefits for donating to charities. This comes at a time when nonprofit organizations desperately need all the funding they can get.
Long-term use of nonaspirin NSAIDs may increase kidney cancer risk
10/20/2011
The absolute risk differences for users versus nonusers of nonaspirin NSAIDs were 9.15 per 100,000 person-years in women and 10.92 per 100,000 person-years in men.
How to Read Your Pathology Report
10/17/2011
Surgical pathology reports vary somewhat regarding the information that they contain; however, each report will document the significant details that affect the management of your diagnosis.
Kidney Cancer Predictive Tools
10/17/2011
CancerNomograms.com is a project of Fox Chase Cancer Center which seeks to be the preeminent source of implementations of the most current and cutting-edge predictive nomograms and other patient health and evaluative models available for a multitude of disease sites.
VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients
10/17/2011
Data presented at the 10th International Kidney Cancer Symposium being held in Chicago, IL show that the pretreatment blood-based test, VeriStrat, was able to stratify renal cell carcinoma (RCC) patients treated with a combination of two targeted therapies, sunitinib (Sutent®) and erlotinib (Tarceva®), by survival outcomes.
Podcast: 10th International Kidney Cancer Symposium
10/15/2011
A report on this medical meeting held annually in downtown Chicago
Ghanaian Actress Starts Kidney Cancer Charity
10/12/2011
Ghanaian actress Juliet Ibrahim is making plans to launch her Juliet Ibrahim Foundation (JIF) in December to start an awareness campaign about cancer of the kidney.
Blue Shield of California won't cover Avastin
10/10/2011
With 3.2 million members, Blue Shield appears to be the largest health insurer so far to stop covering Avastin...
FDA Grants Fast Track Designation to Wilex AG's Rencarex
10/06/2011
RENCAREX® has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) of its investigational compound RENCAREX® which is currently undergoing the pivotal Phase III trial ARISER for the adjuvant treatment of patients with non-metastatic clear cell Renal Cell Carcinoma (ccRCC) at high risk of relapse after surgery.
News Feed